Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | VCEL Vericel Corporation | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $40.02 -0.0% | $15.06 -2.0% |
| StockIQ Score | 59C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 52C- | 13F |
| Fundamental | 54C- | 35F |
| Growth | 79B+ | 50C- |
| Fair Value | 33F | 38F |
| News | 100A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 48D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Vericel (VCEL) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor score (52 vs. 37) and overall rating (MODERATE vs. WEAK) are stronger, while its growth score (79 vs. 50) and fundamental score (54 vs. 35) also lead. AAPG only scores higher in valuation (38 vs. 33), but VCEL’s technical score (23 vs. 18) still surpasses it.
